The store will not work correctly when cookies are disabled.
Cookie Policy:This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
TAK-715 is a potent specific inhibitor of the p38α MAP kinase with an IC(50) of 7.1nM. It is approximately 30-fold more selective for p38α over p38β. It shows no inhibition of p38γ/δ.
Product References
Novel inhibitor of p38 MAP kinase as an anti-TNF-α drug: discovery of N-[4-[2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide (TAK-715) as a potent and orally active anti-rheumatoid arthritis agent: S. Miwatashi, et al.; J. Med. Chem. 48, 5966 (2005)